Abstract
Vector control is a major public health challenge in reducing the transmission of vector-borne diseases. Bacillus thuringiensis israelensis (Bti), an entomopathogenic bacterium, is primarily known for its larvicidal activity against mosquitoes. However, recent research has explored its use as an oral toxin targeting adult mosquitoes through toxic sugar baits. This review highlights the properties, action mechanism, and efficacy of Bti in this formulation. Its appeal lies in its mosquito specificity, low environmental impact, and potential to overcome insecticide resistance. However, challenges remain regarding the optimization of formulations and the assessment of its long-term efficacy in natural conditions. Should the efficacy of the formulations in open environments be confirmed, this innovative approach could serve as a valuable complement to existing strategies and enhance efforts to control vector-borne diseases.